Cancer therapies can cause significant skin, scalp, and nail side effects in nearly two-thirds of patients, impacting comfort ...

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder. Thanks to a new initiative, AOSD is now considered to be ...

EULAR - The European Alliance of Associations for Rheumatology - has identified an unmet clinical need around the assessment ...

By Dennis Thompson HealthDay ReporterFRIDAY, Dec. 12, 2025 (HealthDay News) — Less might be more when it comes to immunotherapy treatment of melanoma, a new study says. Lower doses of a drug used to ...

As fans celebrate the 250th anniversary of Jane Austen’s birth, scholars are still combing over documents to solve the mystery shrouding her final days.

Maureen Kamischke shares with PEOPLE her daughter’s struggle with hepatitis B — and why it’s so important not to delay vaccination. Now 28, her daughter still has liver damage.

As the body’s first line of defense, the skin performs multiple vital functions—it safeguards internal organs, regulates body ...

HYMPAVZI is currently approved in more than 40 countries for the treatment of eligible patients 12 years of age and older living with hemophilia A without factor VIII inhibitors, or hemophilia B ...

Rocatinlimab improved moderate to severe dermatitis in adults, establishing the OX40 receptor as a validated treatment target ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...

Palliative care felt like the only option left for 13-year-old leukaemia patient Alyssa Tapley, until she became the first ...

“The first symptoms of mpox include a high temperature, headache, muscle aches and backache, swollen glands, shivering, ...